Difference between revisions of "Part:BBa K2114009"
(→Characterization) |
|||
(22 intermediate revisions by 3 users not shown) | |||
Line 9: | Line 9: | ||
[[File:iG16_schematic_BBa_K2114009.png|350px|thumb|left|Figure 1: Schematic representation of the resulting fusion protein.]] | [[File:iG16_schematic_BBa_K2114009.png|350px|thumb|left|Figure 1: Schematic representation of the resulting fusion protein.]] | ||
− | This part includes the anti-GFP nanobody | + | This part includes the anti-GFP nanobody <sup>1</sup> fused by an alpha helical linker <sup>2</sup> to the <i>B. subtilis </i> spore crust gene cotG in order to be displayed on the spore surface. The hemagglutinin epitope tag was included in the fusion construct for convenient detection by specific anti-HA antibodies. The cotG gene was amplified from the genome of <i>B. subtilis</i> and the anti-GFP nanobody was amplified from an expression plasmid. The HA tag and the alpha helical linker were introduced by primer extensions. Both PCR fragments were assembled by Gibson cloning into pSB1C3. The fusion construct can be released by XbaI and PstI and cloned alongside with an appropriate promoter into an integration vector for <i>B. subtilis</i> by 3A assembly <sup>3</sup>. |
<br><br><br> | <br><br><br> | ||
<br> | <br> | ||
===Characterization=== | ===Characterization=== | ||
− | This part was used and characterized by | + | This part was used and characterized by [http://2016.igem.org/Team:Freiburg Team Freiburg 2016]. <br> |
+ | |||
+ | |||
<h4>I) Verification of surface localization by flow cytometry</h4> | <h4>I) Verification of surface localization by flow cytometry</h4> | ||
− | [[File: | + | [[File:iG16_Freiburg_Alexa_FACS_BBa_K2114009v2.png|400px|thumb|left|Figure 2: FACS analysis of the surface-displayed fusion construct. Staining of wild type (not transformed) and engineered (expressing BBa_K2114009) spores with anti-HA antibodies conjugated to Alexa Fluor 647.]] |
− | The spores of B. subtilis expressing the part BBa_K2114009 were purified by lysozyme treatment to lyse remaining vegetative cells and stained with anti-HA antibodies conjugated to Alexa Fluor® 647 (Cell Signaling Technology®). The antibody could only access surface-localized HA epitopes of the expressed fusion genes and could confirm the successful display of the heterologous protein on the surface of the modified spores resulting in a slight increase of the fluorescence compared to the stained wild type spores. The low amount of fluorescent spores might be | + | The spores of <i>B. subtilis</i> expressing the part BBa_K2114009 were purified by lysozyme treatment to lyse remaining vegetative cells and stained with anti-HA antibodies conjugated to Alexa Fluor® 647 (Cell Signaling Technology®). The antibody could only access surface-localized HA epitopes of the expressed fusion genes and could confirm the successful display of the heterologous protein on the surface of the modified spores resulting in a slight increase of the fluorescence compared to the stained wild type spores. The low amount of fluorescent spores might be attributable to a low display efficiency using the CotG protein as an anchor. |
+ | <br><br><br> | ||
<br><br><br> | <br><br><br> | ||
<br><br><br> | <br><br><br> | ||
Line 27: | Line 30: | ||
<br><br> | <br><br> | ||
− | <h4>II) | + | <h4>II) Verification of functionality by binding to GFP</h4> |
− | [[File: | + | [[File:iG16_Freiburg_BBa_K2114009_GFP.png|350px|thumb|left|Figure 3: Evaluation of the GFP binding. The spores of <i>B. subtilis</i> expressing the part BBa_K2114009 and wild type spores were incubated with purified GFP and analyzed by flow cytometry. The scatter plots indicates the increase of fluorescence of the spores expressing and displaying the part BBa_K2114009.]] |
− | + | ||
+ | To verify the functionality of the expressed fusion construct containing the anti-GFP nanobody the spores were incubated with purified GFP and analyzed by flow cytometry in order to detect the fluorescence. Spores expressing the part BBa_K2114009 exhibited increased fluorescence in comparison to the unmodified wild type spores (Figure 3). The low amount of fluorescent spores might be attributible to a low display efficiency using the CotG protein as an anchor for the anti-GFP nanobody. | ||
+ | <br><br><br> | ||
+ | <br><br><br> | ||
<br><br><br> | <br><br><br> | ||
<br><br><br> | <br><br><br> |
Latest revision as of 07:05, 20 October 2016
aGFPnano_HA_aHelix_cotG
N-terminal fusion of anti-GFP nanobody to spore coat gene cotG by a alpha helical linker.
Usage and Biology
This part includes the anti-GFP nanobody 1 fused by an alpha helical linker 2 to the B. subtilis spore crust gene cotG in order to be displayed on the spore surface. The hemagglutinin epitope tag was included in the fusion construct for convenient detection by specific anti-HA antibodies. The cotG gene was amplified from the genome of B. subtilis and the anti-GFP nanobody was amplified from an expression plasmid. The HA tag and the alpha helical linker were introduced by primer extensions. Both PCR fragments were assembled by Gibson cloning into pSB1C3. The fusion construct can be released by XbaI and PstI and cloned alongside with an appropriate promoter into an integration vector for B. subtilis by 3A assembly 3.
Characterization
This part was used and characterized by [http://2016.igem.org/Team:Freiburg Team Freiburg 2016].
I) Verification of surface localization by flow cytometry
The spores of B. subtilis expressing the part BBa_K2114009 were purified by lysozyme treatment to lyse remaining vegetative cells and stained with anti-HA antibodies conjugated to Alexa Fluor® 647 (Cell Signaling Technology®). The antibody could only access surface-localized HA epitopes of the expressed fusion genes and could confirm the successful display of the heterologous protein on the surface of the modified spores resulting in a slight increase of the fluorescence compared to the stained wild type spores. The low amount of fluorescent spores might be attributable to a low display efficiency using the CotG protein as an anchor.
II) Verification of functionality by binding to GFP
To verify the functionality of the expressed fusion construct containing the anti-GFP nanobody the spores were incubated with purified GFP and analyzed by flow cytometry in order to detect the fluorescence. Spores expressing the part BBa_K2114009 exhibited increased fluorescence in comparison to the unmodified wild type spores (Figure 3). The low amount of fluorescent spores might be attributible to a low display efficiency using the CotG protein as an anchor for the anti-GFP nanobody.
References
1. Kubala, M. H., Kovtun, O., Alexandrov, K. & Collins, B. M. Structural and thermodynamic analysis of the GFP:GFP-nanobody complex. Protein Sci. 19, 2389–2401 (2010).
2. Hinc, K., Iwanicki, A. & Obuchowski, M. New stable anchor protein and peptide linker suitable for successful spore surface display in B. subtilis. Microb. Cell Fact. 12, 22 (2013).
3. Radeck, J. et al. The Bacillus BioBrick Box: generation and evaluation of essential genetic building blocks for standardized work with Bacillus subtilis. J. Biol. Eng. 7, 29 (2013).
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]